Schubert & Co’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Schubert & Co’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-6	Closed	–	–	1662
2022 Q2	$0	Buy	6 +4	+200%	+$178	﹤0.01%	1656
2022 Q1	$0	Buy	+2	New	+$67	﹤0.01%	1425

Schubert & Co's TPTX Position: Q3 2022 in Review

Schubert & Co sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 6 shares.

Schubert & Co first reported a position in TPTX in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

Schubert & Co reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Schubert & Co sold 6 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022.
Schubert & Co first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
Schubert & Co's Turning Point Therapeutics, Inc. Common Stock position peaked at $0 in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Schubert & Co's 13F filing for Q3 2022, filed 21 Oct 2022.